Itonic (ITOC) Competitors

$0.34 -0.01 (-1.71%)

Closing price 03:59 PM Eastern

Extended Trading

$0.34 0.00 (-0.87%)

As of 04:05 PM Eastern

ITOC vs. OSRH, ICCM, FEMY, POAI, and RVP

Should you be buying Itonic stock or one of its competitors? The main competitors of Itonic include OSR (OSRH), IceCure Medical (ICCM), Femasys (FEMY), Predictive Oncology (POAI), and Retractable Technologies (RVP). These companies are all part of the "medical equipment" industry.

How does Itonic compare to OSR?

Itonic (NASDAQ:ITOC) and OSR (NASDAQ:OSRH) are both small-cap manufacturing companies, but which is the better investment? We will compare the two companies based on the strength of their earnings, valuation, dividends, risk, profitability, analyst recommendations, media sentiment and institutional ownership.

: In the previous week, OSR had 1 more articles in the media than Itonic. MarketBeat recorded 2 mentions for OSR and 1 mentions for Itonic. OSR's average media sentiment score of 0.00 beat Itonic's score of -0.84 indicating that OSR is being referred to more favorably in the news media.
Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Itonic
0 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Negative
OSR
0 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
: Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Itonic
1 Sell rating(s)
0 Hold rating(s)

0 Buy rating(s)

0 Strong Buy rating(s)
1.00
OSR
1 Sell rating(s)

0 Hold rating(s)

0 Buy rating(s)

0 Strong Buy rating(s)
1.00
: Itonic has higher earnings, but lower revenue than OSR.
Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Itonic $523.03K 11.25 -$5.10M N/A N/A
OSR $2.91M 5.94 -$27.06M -$1.28 N/A
: Itonic has a beta of 3.23, meaning that its share price is 223% more volatile than the S&P 500. Comparatively, OSR has a beta of 0.86, meaning that its share price is 14% less volatile than the S&P 500.
: 55.3% of OSR shares are owned by institutional investors. 60.6% of OSR shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.
: Itonic has a net margin of 0.00% compared to OSR's net margin of -619.82%. Itonic's return on equity of 0.00% beat OSR's return on equity.
Company Net Margins Return on Equity Return on Assets
Itonic N/A N/A N/A
OSR -619.82% -13.53% -10.17%

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Itonic	0 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Negative
OSR	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Itonic	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
OSR	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Itonic	$523.03K	11.25	-$5.10M	N/A	N/A
OSR	$2.91M	5.94	-$27.06M	-$1.28	N/A

Company	Net Margins	Return on Equity	Return on Assets
Itonic	N/A	N/A	N/A
OSR	-619.82%	-13.53%	-10.17%

Summary

Itonic beats OSR on 6 of the 11 factors compared between the two stocks.

How does Itonic compare to IceCure Medical?

Itonic (NASDAQ:ITOC) and IceCure Medical (NASDAQ:ICCM) are both small-cap medical equipment companies, but which is the better investment? We will compare the two companies based on the strength of their earnings, valuation, dividends, risk, profitability, analyst recommendations, media sentiment and institutional ownership.

: 0.6% of IceCure Medical shares are owned by institutional investors. 2.4% of IceCure Medical shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.
: In the previous week, Itonic and Itonic both had 1 articles in the media. IceCure Medical's average media sentiment score of 0.00 beat Itonic's score of -0.84 indicating that IceCure Medical is being referred to more favorably in the news media.
Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Itonic
0 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Negative
IceCure Medical
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
: Itonic has higher earnings, but lower revenue than IceCure Medical.
Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Itonic $523.03K 11.25 -$5.10M N/A N/A
IceCure Medical $3.38M 6.72 -$15.06M -$0.24 N/A
: IceCure Medical has a consensus price target of $2.64, indicating a potential upside of 841.07%. Given IceCure Medical's stronger consensus rating and higher possible upside, analysts clearly believe IceCure Medical is more favorable than Itonic.
Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Itonic
1 Sell rating(s)
0 Hold rating(s)

0 Buy rating(s)

0 Strong Buy rating(s)
1.00
IceCure Medical
1 Sell rating(s)

1 Hold rating(s)

2 Buy rating(s)

0 Strong Buy rating(s)
2.25
: Itonic has a beta of 3.23, meaning that its share price is 223% more volatile than the S&P 500. Comparatively, IceCure Medical has a beta of 0.47, meaning that its share price is 53% less volatile than the S&P 500.
: Itonic has a net margin of 0.00% compared to IceCure Medical's net margin of -445.61%. Itonic's return on equity of 0.00% beat IceCure Medical's return on equity.
Company Net Margins Return on Equity Return on Assets
Itonic N/A N/A N/A
IceCure Medical -445.61% -221.04% -118.89%

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Itonic	0 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Negative
IceCure Medical	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Itonic	$523.03K	11.25	-$5.10M	N/A	N/A
IceCure Medical	$3.38M	6.72	-$15.06M	-$0.24	N/A

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Itonic	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
IceCure Medical	1 Sell rating(s)	1 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.25

Company	Net Margins	Return on Equity	Return on Assets
Itonic	N/A	N/A	N/A
IceCure Medical	-445.61%	-221.04%	-118.89%

Summary

IceCure Medical beats Itonic on 7 of the 13 factors compared between the two stocks.

How does Itonic compare to Femasys?

Itonic (NASDAQ:ITOC) and Femasys (NASDAQ:FEMY) are both small-cap medical equipment companies, but which is the superior investment? We will compare the two businesses based on the strength of their risk, earnings, profitability, dividends, analyst recommendations, valuation, media sentiment and institutional ownership.

: 65.3% of Femasys shares are owned by institutional investors. 7.6% of Femasys shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.
: In the previous week, Itonic and Itonic both had 1 articles in the media. Femasys' average media sentiment score of 0.00 beat Itonic's score of -0.84 indicating that Femasys is being referred to more favorably in the news media.
Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Itonic
0 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Negative
Femasys
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
: Itonic has higher earnings, but lower revenue than Femasys.
Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Itonic $523.03K 11.25 -$5.10M N/A N/A
Femasys $2.29M 10.65 -$18.63M -$0.50 N/A
: Femasys has a consensus price target of $5.50, indicating a potential upside of 1,261.39%. Given Femasys' stronger consensus rating and higher possible upside, analysts clearly believe Femasys is more favorable than Itonic.
Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Itonic
1 Sell rating(s)
0 Hold rating(s)

0 Buy rating(s)

0 Strong Buy rating(s)
1.00
Femasys
1 Sell rating(s)

0 Hold rating(s)

4 Buy rating(s)

0 Strong Buy rating(s)
2.60
: Itonic has a beta of 3.23, meaning that its stock price is 223% more volatile than the S&P 500. Comparatively, Femasys has a beta of -2.26, meaning that its stock price is 326% less volatile than the S&P 500.
: Itonic has a net margin of 0.00% compared to Femasys' net margin of -812.74%. Itonic's return on equity of 0.00% beat Femasys' return on equity.
Company Net Margins Return on Equity Return on Assets
Itonic N/A N/A N/A
Femasys -812.74% -534.94% -116.29%

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Itonic	0 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Negative
Femasys	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Itonic	$523.03K	11.25	-$5.10M	N/A	N/A
Femasys	$2.29M	10.65	-$18.63M	-$0.50	N/A

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Itonic	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Femasys	1 Sell rating(s)	0 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.60

Company	Net Margins	Return on Equity	Return on Assets
Itonic	N/A	N/A	N/A
Femasys	-812.74%	-534.94%	-116.29%

Summary

Femasys beats Itonic on 7 of the 13 factors compared between the two stocks.

How does Itonic compare to Predictive Oncology?

Itonic (NASDAQ:ITOC) and Predictive Oncology (NASDAQ:POAI) are both small-cap medical equipment companies, but which is the better business? We will contrast the two businesses based on the strength of their valuation, earnings, profitability, dividends, analyst recommendations, risk, media sentiment and institutional ownership.

: Itonic has a net margin of 0.00% compared to Predictive Oncology's net margin of -5,065.23%. Itonic's return on equity of 0.00% beat Predictive Oncology's return on equity.
Company Net Margins Return on Equity Return on Assets
Itonic N/A N/A N/A
Predictive Oncology -5,065.23% -732.73% -235.55%
: 9.0% of Predictive Oncology shares are owned by institutional investors. 1.2% of Predictive Oncology shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.
: In the previous week, Itonic and Itonic both had 1 articles in the media. Predictive Oncology's average media sentiment score of 0.00 beat Itonic's score of -0.84 indicating that Predictive Oncology is being referred to more favorably in the news media.
Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Itonic
0 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Negative
Predictive Oncology
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
: Itonic has a beta of 3.23, meaning that its share price is 223% more volatile than the S&P 500. Comparatively, Predictive Oncology has a beta of 1.35, meaning that its share price is 35% more volatile than the S&P 500.
: Itonic has higher earnings, but lower revenue than Predictive Oncology.
Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Itonic $523.03K 11.25 -$5.10M N/A N/A
Predictive Oncology $1.66M 10.60 -$12.66M -$13.50 N/A
: Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Itonic
1 Sell rating(s)
0 Hold rating(s)

0 Buy rating(s)

0 Strong Buy rating(s)
1.00
Predictive Oncology
1 Sell rating(s)

0 Hold rating(s)

0 Buy rating(s)

0 Strong Buy rating(s)
1.00

Company	Net Margins	Return on Equity	Return on Assets
Itonic	N/A	N/A	N/A
Predictive Oncology	-5,065.23%	-732.73%	-235.55%

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Itonic	0 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Negative
Predictive Oncology	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Itonic	$523.03K	11.25	-$5.10M	N/A	N/A
Predictive Oncology	$1.66M	10.60	-$12.66M	-$13.50	N/A

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Itonic	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Predictive Oncology	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Summary

Itonic beats Predictive Oncology on 6 of the 10 factors compared between the two stocks.

How does Itonic compare to Retractable Technologies?

Itonic (NASDAQ:ITOC) and Retractable Technologies (NYSE:RVP) are both small-cap medical equipment companies, but which is the better business? We will contrast the two businesses based on the strength of their valuation, earnings, profitability, dividends, analyst recommendations, risk, media sentiment and institutional ownership.

: Itonic has a net margin of 0.00% compared to Retractable Technologies' net margin of -41.11%. Itonic's return on equity of 0.00% beat Retractable Technologies' return on equity.
Company Net Margins Return on Equity Return on Assets
Itonic N/A N/A N/A
Retractable Technologies -41.11% -17.15% -9.33%
: 7.6% of Retractable Technologies shares are owned by institutional investors. 59.5% of Retractable Technologies shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.
: In the previous week, Itonic and Itonic both had 1 articles in the media. Retractable Technologies' average media sentiment score of 0.00 beat Itonic's score of -0.84 indicating that Retractable Technologies is being referred to more favorably in the news media.
Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Itonic
0 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Negative
Retractable Technologies
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
: Itonic has a beta of 3.23, meaning that its share price is 223% more volatile than the S&P 500. Comparatively, Retractable Technologies has a beta of 1.25, meaning that its share price is 25% more volatile than the S&P 500.
: Itonic has higher earnings, but lower revenue than Retractable Technologies.
Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Itonic $523.03K 11.25 -$5.10M N/A N/A
Retractable Technologies $38.27M 0.57 -$7.01M -$0.42 N/A
: Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Itonic
1 Sell rating(s)
0 Hold rating(s)

0 Buy rating(s)

0 Strong Buy rating(s)
1.00
Retractable Technologies
0 Sell rating(s)

0 Hold rating(s)

0 Buy rating(s)

0 Strong Buy rating(s)
0.00

Company	Net Margins	Return on Equity	Return on Assets
Itonic	N/A	N/A	N/A
Retractable Technologies	-41.11%	-17.15%	-9.33%

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Itonic	0 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Negative
Retractable Technologies	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Itonic	$523.03K	11.25	-$5.10M	N/A	N/A
Retractable Technologies	$38.27M	0.57	-$7.01M	-$0.42	N/A

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Itonic	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Retractable Technologies	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00

Summary

Itonic beats Retractable Technologies on 7 of the 11 factors compared between the two stocks.

Get Itonic News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding ITOC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

ITOC vs. The Competition

Export

Metric	Itonic	Surgical, Medical, And Dental Instruments And Supplies Industry	Manufacturing Sector	NASDAQ Exchange
Market Cap	$5.88M	$3.86B	$4.21B	$11.87B
Dividend Yield	N/A	N/A	5.61%	5.21%
P/E Ratio	N/A	4.04	23.40	28.47
Price / Sales	11.25	323.18	188.22	60.92
Price / Cash	N/A	3.96	52.82	36.52
Price / Book	0.72	3.83	38.44	6.67
Net Income	-$5.10M	-$76.79M	$114.66M	$332.53M
7 Day Performance	-13.62%	-0.33%	1.34%	2.03%
1 Month Performance	13.04%	-1.92%	5.68%	9.23%
1 Year Performance	N/A	52.89%	18.76%	39.62%

Itonic Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
ITOC Itonic	N/A	$0.35 -1.7%	N/A	N/A	$5.88M	$523.03K	N/A	N/A	Gap Down
OSRH OSR	0.9242 of 5 stars	$0.70 +52.6%	N/A	N/A	$23.25M	$2.91M	N/A	N/A	Gap Down High Trading Volume
ICCM IceCure Medical	2.1551 of 5 stars	$0.27 +1.4%	$2.64 +861.7%	N/A	$22.24M	$3.38M	N/A	60	News Coverage Analyst Forecast
FEMY Femasys	1.8042 of 5 stars	$0.36 -3.2%	$5.50 +1,423.5%	N/A	$21.80M	$2.29M	N/A	30	News Coverage Upcoming Earnings Gap Up
POAI Predictive Oncology	0.0388 of 5 stars	$5.64 -4.9%	N/A	N/A	$19.14M	$1.66M	N/A	30	News Coverage Gap Down

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:ITOC) was last updated on 5/5/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Itonic (ITOC) Competitors

ITOC vs. OSRH, ICCM, FEMY, POAI, and RVP

How does Itonic compare to OSR?

Summary

How does Itonic compare to IceCure Medical?

Summary

How does Itonic compare to Femasys?

Summary

How does Itonic compare to Predictive Oncology?

Summary

How does Itonic compare to Retractable Technologies?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

ITOC vs. The Competition

Itonic Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Itonic (ITOC) Competitors

ITOC vs. OSRH, ICCM, FEMY, POAI, and RVP

How does Itonic compare to OSR?

Summary

How does Itonic compare to IceCure Medical?

Summary

How does Itonic compare to Femasys?

Summary

How does Itonic compare to Predictive Oncology?

Summary

How does Itonic compare to Retractable Technologies?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

ITOC vs. The Competition

Itonic Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools